CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: aztreonam
Accession: CHEBI:161680
browse the term
Definition: A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Synonyms: exact_synonym: (2S,3S)-3-{(2Z)-2-(2-ammonio-1,3-thiazol-4-yl)-2-[(2-carboxypropan-2-yloxy)imino]acetamido}-2-methyl-4-oxoazetidine-1-sulfonate
related_synonym: (Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid; AZT; Azactam; Formula=C13H17N5O8S2; InChI=1S/C13H17N5O8S2/c1-5-7(10(20)18(5)28(23,24)25)16-9(19)8(6-4-27-12(14)15-6)17-26-13(2,3)11(21)22/h4-5,7H,1-3H3,(H2,14,15)(H,16,19)(H,21,22)(H,23,24,25)/b17-8-/t5-,7-/m0/s1; InChIKey=WZPBZJONDBGPKJ-VEHQQRBSSA-N; Primbactam; SMILES=C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\\c2csc([NH3+])n2)C(=O)N1S([O-])(=O)=O; aztreonamum
alt_id: CHEBI:2960; CHEBI:41008
xref: Beilstein:3577211; CAS:78110-38-0; DrugBank:DB00355; Drug_Central:279; KEGG:C06840; KEGG:D00240
xref_mesh: MESH:D001398
xref: PDBeChem:AZR; PMID:1384868; PMID:15123864; PMID:24119095; PMID:24176390; PMID:24369293; PMID:25049240; PMID:25091537; PMID:25295210; PMID:28543395; PMID:29017833; Patent:NL8100571; Reaxys:3577211; Wikipedia:Aztreonam
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
ISO
Aztreonam results in increased expression of ABCC2 mRNA
CTD
PMID:24657338
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcg5
ATP binding cassette subfamily G member 5
increases expression
ISO
Aztreonam results in increased expression of ABCG5 mRNA
CTD
PMID:24657338
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
increases expression
ISO
Aztreonam results in increased expression of ABCG8 mRNA
CTD
PMID:24657338
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
decreases expression
ISO
Aztreonam results in decreased expression of NPC1L1 mRNA
CTD
PMID:24657338
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
increases expression
ISO
Aztreonam results in increased expression of NR5A2 mRNA
CTD
PMID:24657338
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
RT1-Ha
RT1 class II, locus Ha
affects expression
ISO
Aztreonam affects the expression of HLA-DPA1 mRNA
CTD
PMID:25811541
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
G
Slc10a1
solute carrier family 10 member 1
increases expression
ISO
Aztreonam results in increased expression of SLC10A1 mRNA
CTD
PMID:24657338
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc10a2
solute carrier family 10 member 2
decreases expression
ISO
Aztreonam results in decreased expression of SLC10A2 mRNA
CTD
PMID:24657338
NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475
G
Slc51b
SLC51 subunit beta
decreases expression
ISO
Aztreonam results in decreased expression of SLC51B mRNA
CTD
PMID:24657338
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all